Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2025-02-04 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
关于控股股东股权结构拟发生变更的进展公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding a change in the equity structure of the controlling shareholder of the company. It details the progress of a share transfer agreement and related approvals but does not contain financial statements or detailed financial data. The document is relatively short (707 characters) and focuses on shareholder structure changes rather than financial results or management discussion. This fits the category of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or controlling shareholder changes.
2025-02-04 Chinese
关于实际控制人发生变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in the company's actual controlling shareholder and related equity transfer progress. It details the timeline of disclosures about the change in control, approvals from regulatory bodies, and the completion of the equity transfer registration. The document does not contain financial statements or detailed financial analysis but is a formal announcement of a significant change in ownership and control. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about ownership change and does not fit into more specific categories like Major Shareholding Notification (MRQ) because it concerns the actual controller change and related approvals rather than just shareholding thresholds crossing. The document length is short (1457 characters), and it is not a report or a presentation but an official announcement.
2025-01-24 Chinese
关于实际控制人拟发生变更事项的进展公告
Regulatory Filings Classification · 95% confidence The document is a progress announcement regarding the change of the actual controller of the company, detailing various disclosures and approvals related to the transfer of state-owned equity shares. It includes dates and references to previous announcements and legal opinions but does not contain financial statements or detailed financial data. The document is relatively short (1236 characters) and serves as an update on a corporate control change process rather than a full report or financial filing. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about ownership/control changes without being a formal report or proxy statement.
2025-01-17 Chinese
关于控股股东股权结构拟发生变更的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a short announcement (947 characters) regarding a proposed change in the equity structure of the company's controlling shareholder. It details a share transfer agreement and its expected impact on the company, emphasizing that the controlling shareholder remains the same and that business operations will not be affected. There are no financial statements, no detailed financial data, no mention of a report being attached or published, and no regulatory certifications. The content fits the description of a Major Shareholding Notification (MRQ) as it informs about changes in significant share ownership levels, even though the ultimate controlling shareholder remains unchanged. Therefore, the document is best classified as a Major Shareholding Notification (MRQ).
2025-01-10 Chinese
2024年度业绩预告
Earnings Release Classification · 95% confidence The document is titled as a "2024年度业绩预告" which translates to "2024 Annual Performance Forecast" or "Earnings Forecast". It provides estimated financial results for the full year 2024, including net profit and earnings per share, with comparisons to the prior year. It explicitly states that the financial data have not been audited yet and that detailed financial data will be disclosed in the 2024 Annual Report. The document is short (766 characters) and serves as a preliminary earnings forecast rather than a full financial report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks detailed financial statements and analysis. It is not a Report Publication Announcement (RPA) because it contains substantive financial forecast data, not just a notice of report availability. FY 2024
2025-01-10 Chinese
关于控股子公司获得药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding a subsidiary obtaining a drug registration certificate from the national drug regulatory authority. It details the drug's registration information, background, and potential impact on the company. There is no financial data, no mention of a report being attached or published, and no indication of a regulatory filing or certification. The content is an official announcement about a regulatory approval event affecting the company’s operations and future prospects. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-01-09 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.